Core Viewpoint - Chengdu Huawi (688709.SH) announced that its shareholders plan to reduce their holdings due to personal funding needs, with a total reduction of up to 2.8576% of the company's shares [1] Summary by Categories Shareholder Actions - Shareholders Huawi Zhongzhi, Huawi Zhanfei, Huawi Tongchuang, and Huawi Gongrong have issued a notice regarding their share reduction plan [1] - The reduction is planned to occur within 15 trading days from the announcement or within three months after three trading days from the announcement [1] Reduction Details - The total shares to be reduced by the shareholders amount to no more than 2.8576% of the company's total shares [1] - The reduction will be executed through centralized bidding or block trading methods [1]

Core Viewpoint - Chengdu Huawi (688709.SH) announced that its shareholders plan to reduce their holdings due to personal funding needs, with a total reduction of up to 2.8576% of the company's shares [1] Shareholder Reduction Plan - The shareholders involved in the reduction plan include Huawi Zhongzhi, Huawi Zhanfei, Huawi Tongchuang, and Huawi Gongrong [1] - The reduction is planned to occur within 15 trading days from the announcement date or within three months after three trading days [1] - The shares will be reduced through centralized bidding or block trading methods [1]

成都华微电子科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，成都华微电子科技股份有限公司（以下简称"公司"） 的股东成都华微众志共创企业管理中心（有限合伙）（以下简称"华微众志"）持 有公司股份 48,776,536 股，占公司总股本的 7.6591%；股东成都华微展飞伙伴 企业管理中心（有限合伙）（以下简称"华微展飞"）持有公司股份 15,635,708 股，占公司总股本的 2.4552%；股东成都华微同创共享企业管理中心（有限合伙） （以下简称"华微同创"）持有公司股份 12,850,171 股，占公司总股本的 2.0178%； 股东成都华微共融众创企业管理中心（有限合伙）（以下简称"华微共融"）持有 公司股份 9,974,703 股，占公司总股本的 1.5663%。 减持计划的主要内容 证券代码：688709 证券简称：成都华微 公告编号：2025-042 公司于近日收到股东华微众志、华微展飞、华微同创、华微共融 ...

Core Viewpoint - Chengdu Huawi announced that shareholders Huawi Zhongzhi, Huawi Zhanfei, Huawi Tongchuang, and Huawi Gongrong plan to reduce their holdings within three months through centralized bidding or block trading, affecting a total of 1,819.91 million shares, which represents approximately 2.8596% of the company's total share capital [1] Summary by Categories - **Shareholder Actions** - Huawi Zhongzhi intends to reduce holdings by up to 6.172 million shares, accounting for 0.9692% of the total share capital [1] - Huawi Zhanfei plans to reduce holdings by up to 4.1303 million shares, representing 0.6486% of the total share capital [1] - Huawi Tongchuang aims to reduce holdings by up to 4.1268 million shares, which is 0.6480% of the total share capital [1] - Huawi Gongrong will reduce holdings by up to 3.769 million shares, making up 0.5918% of the total share capital [1]

成都华微在互动平台表示，公司目前NOR Flash产品已形成大、中、小容量三个系列，覆盖512Kbit- 1Gbit等容量类型，所有产品均进入批量供货阶段，可应用于FPGA配置存储器及独立数据存储场景。对 于在研的2Gbit大容量NOR Flash，公司严格遵循研发流程推进研发、测试及验证。 ...

Core Viewpoint - Chengdu Huami (688709.SH) has developed NOR Flash products in three series with capacities ranging from 512Kbit to 1Gbit, all of which are now in mass production and applicable in FPGA configuration memory and independent data storage scenarios [1] Group 1: Product Development and Market Position - The company focuses on key core technology breakthroughs and enhances R&D investment and technological innovation capabilities to ensure high reliability of products in complex environments [1] - The company has established a comprehensive patent protection system for its intellectual property, with specific patent data to be disclosed in periodic reports [1] - The company will disclose data on the shipment volume, revenue contribution, and global market share of NOR Flash products starting from 2025 in accordance with regulatory requirements [1] Group 2: Application and Customer Recognition - The company's products have been recognized by mainstream manufacturers in the special integrated circuit industry and are widely used in specialized scenarios, although specific order distribution details are not disclosed due to commercial sensitivity [1] - The company is strictly following R&D processes for the development, testing, and validation of its 2Gbit high-capacity NOR Flash [1] - The company will adhere to information disclosure regulations, with updates on product R&D progress and specific release dates based on actual development status [1] Group 3: Future Focus - The company will continue to focus on key core technology breakthroughs, strengthen R&D investment and technological innovation capabilities, and closely monitor cutting-edge technology trends and customer needs to expand application scenarios as appropriate [1]

Core Viewpoint - Chengdu Huami (688709.SH) is actively developing brain-computer interface technology, focusing on providing foundational hardware components for signal processing, including high-precision ADCs and low-power FPGAs and MCUs [1] Group 1: Company Developments - The company has leveraged its integrated circuit design advantages to establish a presence in the brain-computer interface sector [1] - Key projects in collaboration with universities such as Shanghai Jiao Tong University and Tianjin University have been completed, covering both invasive and non-invasive brain-computer interface signal chain requirements [1] - The company maintains strong collaborative relationships with several higher education institutions and research organizations, including University of Electronic Science and Technology of China, Xi'an University of Electronic Science and Technology, and National University of Defense Technology [1] Group 2: Future Plans - The company will closely monitor trends in cutting-edge technology and explore new collaboration opportunities in line with its R&D strengths [1] - The company emphasizes the importance of industry-academia-research collaborative innovation and will fulfill information disclosure obligations for any new cooperation plans [1]

Core Viewpoint - Chengdu Huami (688709.SH) has developed NOR Flash products in three series with capacities ranging from 512Kbit to 1Gbit, all of which are now in mass production and applicable in FPGA configuration memory and independent data storage scenarios [1] Group 1: Product Development and Market Position - The company has focused on key core technology breakthroughs, enhancing R&D investment and technological innovation capabilities to ensure high reliability of products in complex environments [1] - The company has established a comprehensive patent protection system, emphasizing the importance of technological innovation [1] - The company will disclose data on the shipment volume, revenue contribution, and global market share of NOR Flash products starting from 2025 in regular reports as per regulatory requirements [1] Group 2: Application and Recognition - The company's products have been recognized by mainstream manufacturers in the special integrated circuit industry and are widely used in special scenarios [1] - Specific order distribution details are not disclosed due to commercial sensitivity [1] Group 3: Future Development - The company is strictly following R&D processes for the development, testing, and validation of the 2Gbit high-capacity NOR Flash [1] - Future disclosures regarding product R&D progress and specific release dates will be based on actual R&D conditions, adhering to information disclosure regulations [1] - The company will continue to focus on key core technology breakthroughs and closely monitor cutting-edge technology trends and customer needs to expand application scenarios as appropriate [1]

Core Viewpoint - The A-share market is experiencing a surge in brain-computer interface concept stocks, driven by the approval of a domestically developed implantable wireless brain-computer interface system entering the special review process by the National Medical Products Administration of China, marking a significant step in the commercialization of this technology in China [1] Group 1: Stock Performance - Aipeng Medical saw a nearly 12% increase in stock price, with a total market value of 40.03 billion and a year-to-date increase of 80.63% [2] - Century Huatong and Innovative Medical both rose over 7%, with market values of 141.1 billion and 10.5 billion respectively, and year-to-date increases of 269.65% and 198.87% [2] - Botao Biological increased by over 5%, with a market value of 6.62 billion and a year-to-date increase of 95.06% [2] - Xiangyu Medical rose over 4%, with a market value of 8.33 billion and a year-to-date increase of 78.19% [2] - Other notable stocks include Sanbo Brain Science, Saily Medical, Dineike, Taihe Technology, and Chengyi Tong, all showing increases of over 3% [1][2] Group 2: Industry Development - The implantable wireless brain-computer interface system developed by Shanghai Ladder Medical Technology Co., Ltd. is the first invasive brain-computer interface product to enter the "green channel" for innovative medical devices in China, indicating a key advancement from clinical validation to market access in this cutting-edge technology field [1]

Core Insights - Chengdu Huamei's stock price decreased by 1.68% on November 11, with a trading volume of 159 million yuan, indicating a decline in investor sentiment [1] - The company reported a financing net buy of -3.41 million yuan on the same day, with a total financing and securities balance of 437 million yuan, which is 4.88% of its market capitalization [1] - For the first nine months of 2025, Chengdu Huamei achieved a revenue of 518 million yuan, a year-on-year increase of 22.45%, while its net profit attributable to shareholders decreased by 28.82% to 62.61 million yuan [2] Financing and Securities - On November 11, Chengdu Huamei had a financing buy of 16.32 million yuan and a financing repayment of 19.73 million yuan, resulting in a net financing outflow [1] - The current financing balance of 437 million yuan is above the 80th percentile of the past year, indicating a high level of leverage [1] - The company had no shares repaid in securities lending on November 11, with a total of 200 shares sold, amounting to 8,210 yuan [1] Shareholder Structure - As of September 30, 2025, the number of shareholders increased by 65.15% to 21,700, while the average circulating shares per person decreased by 39.45% to 10,061 shares [2] - Notable changes in institutional holdings include a decrease in shares held by the top ten circulating shareholders, with new entrants such as Hong Kong Central Clearing Limited and Southern CSI 1000 ETF [3]